AU Stock MarketDetailed Quotes
OSLO OncoSil Medical Ltd
- 0.001
- 0.0000.00%
20min DelayNot Open Jun 28 10:43 AET
3.33MMarket Cap0.00P/E (Static)
0.001High0.001Low504.00KVolume0.001Open0.001Pre Close504.00Turnover0.00652wk High0.02%Turnover Ratio3.33BShares0.00152wk Low--EPS TTM2.79MFloat Cap0.006Historical High0.00P/E (Static)2.79BShs Float0.001Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
OncoSil Medical Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||
| Cash income from operating activities | 8.48%1.19M | -64.79%1.1M | -18.05%3.12M | -11.16%3.81M | 24.37%4.29M | 3.45M |
| Revenue from customers | 38.67%370.48K | 26.65%267.16K | --210.94K | ---- | ---- | ---- |
| Income from government grants | -1.22%821.48K | -71.42%831.6K | 3,169.07%2.91M | --89K | ---- | ---- |
| Other cash income from operating activities | ---- | ---- | ---- | -13.23%3.72M | 24.37%4.29M | --3.45M |
| Cash paid | -12.14%-12.56M | 6.69%-11.2M | -43.61%-12M | 30.30%-8.36M | -0.03%-11.99M | -11.99M |
| Payments to suppliers for goods and services | -12.14%-12.56M | 6.69%-11.2M | -43.61%-12M | 30.30%-8.36M | -0.03%-11.99M | ---11.99M |
| Direct interest paid | 44.46%-10.9K | -24.62%-19.62K | -42.06%-15.75K | ---11.09K | ---- | ---- |
| Direct interest received | 517.97%62.61K | -87.72%10.13K | -21.36%82.48K | -48.62%104.88K | 41.00%204.11K | --144.76K |
| Operating cash flow | -11.92%-11.32M | -14.69%-10.11M | -97.83%-8.82M | 40.59%-4.46M | 10.67%-7.5M | ---8.4M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -891.41%-57.82K | 89.20%-5.83K | -160.61%-54K | -39.74%-20.72K | -38.63%-14.83K | -10.7K |
| Net PPE purchase and sale | -891.41%-57.82K | 89.20%-5.83K | -160.61%-54K | -39.74%-20.72K | -38.63%-14.83K | ---10.7K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | -891.41%-57.82K | 89.20%-5.83K | -160.61%-54K | -39.74%-20.72K | -38.63%-14.83K | ---10.7K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 3.62%9.49M | 8,129.98%9.16M | -99.37%111.25K | 17.79M | 15.61M | |
| Net issuance payments of debt | ---- | ---- | -200.00%-26.56K | --26.56K | ---- | ---- |
| Net common stock issuance | 3.85%9.67M | 3,483.17%9.32M | -98.55%260K | --17.88M | ---- | --15.61M |
| Net other financing activities | -16.84%-187.21K | -31.14%-160.23K | -0.90%-122.18K | ---121.1K | ---- | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 3.62%9.49M | 8,129.98%9.16M | -99.37%111.25K | --17.79M | ---- | --15.61M |
| Net cash flow | ||||||
| Beginning cash position | -7.84%11.28M | -41.71%12.24M | 173.08%21M | -49.43%7.69M | 90.05%15.21M | --8M |
| Current changes in cash | -96.46%-1.89M | 89.04%-960K | -165.81%-8.76M | 277.07%13.31M | -204.32%-7.52M | --7.2M |
| End cash Position | -16.72%9.39M | -7.84%11.28M | -41.71%12.24M | 173.08%21M | -49.43%7.69M | --15.21M |
| Free cash from | -12.43%-11.37M | -14.06%-10.12M | -98.12%-8.87M | 40.44%-4.48M | 10.61%-7.52M | ---8.41M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg